MLYS
Price
$25.64
Change
-$0.45 (-1.72%)
Updated
Aug 14 closing price
Capitalization
2.27B
3 days until earnings call
Intraday BUY SELL Signals
MNKD
Price
$3.85
Change
+$0.12 (+3.22%)
Updated
Aug 14 closing price
Capitalization
1.23B
87 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLYS vs MNKD

MLYS vs MNKD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLYS vs. MNKD commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Hold and MNKD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2026
Stock price -- (MLYS: $25.64 vs. MNKD: $3.85)
Brand notoriety: MLYS and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 44% vs. MNKD: 52%
Market capitalization -- MLYS: $2.27B vs. MNKD: $1.23B
MLYS [@Biotechnology] is valued at $2.27B. MNKD’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $128.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 1 FA rating(s) are green whileMNKD’s FA Score has 1 green FA rating(s).

  • MLYS’s FA Score: 1 green, 4 red.
  • MNKD’s FA Score: 1 green, 4 red.
According to our system of comparison, MLYS is a better buy in the long-term than MNKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 4 TA indicator(s) are bullish while MNKD’s TA Score has 2 bullish TA indicator(s).

  • MLYS’s TA Score: 4 bullish, 5 bearish.
  • MNKD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than MNKD.

Price Growth

MLYS (@Biotechnology) experienced а -6.25% price change this week, while MNKD (@Biotechnology) price change was -6.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was +2992.28%.

Reported Earning Dates

MLYS is expected to report earnings on Aug 18, 2026.

MNKD is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($2.27B) has a higher market cap than MNKD($1.24B). MLYS YTD gains are higher at: -29.347 vs. MNKD (-32.099). MNKD has higher annual earnings (EBITDA): 27.6M vs. MLYS (-171.45M). MLYS has more cash in the bank: 646M vs. MNKD (134M). MNKD has higher revenues than MLYS: MNKD (361M) vs MLYS (0).
MLYSMNKDMLYS / MNKD
Capitalization2.27B1.24B184%
EBITDA-171.45M27.6M-621%
Gain YTD-29.347-32.09991%
P/E RatioN/A143.00-
Revenue0361M-
Total Cash646M134M482%
Total DebtN/A331M-
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSMNKD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signal:
Gain/Loss:
MNKD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AMDG99.8011.28
+12.74%
Leverage Shares 2X Long AMD Daily ETF
TDSC28.690.01
+0.04%
ETC Cabana Target Drawdown 10 ETF
ZTR6.76N/A
N/A
Virtus Total Return Fund
CLM7.35-0.03
-0.39%
Cornerstone Strategic Value Fund
SAPH38.01-0.40
-1.03%
SAP SE ADRHEDGED

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with CYTK. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-1.72%
CYTK - MLYS
59%
Loosely correlated
+0.93%
IONS - MLYS
57%
Loosely correlated
+2.45%
VCYT - MLYS
33%
Loosely correlated
-3.17%
MNKD - MLYS
33%
Loosely correlated
+3.22%
SANA - MLYS
32%
Poorly correlated
-3.27%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+3.22%
VCYT - MNKD
44%
Loosely correlated
-3.17%
IONS - MNKD
40%
Loosely correlated
+2.45%
CYTK - MNKD
38%
Loosely correlated
+0.93%
UTHR - MNKD
37%
Loosely correlated
-0.31%
AMRN - MNKD
36%
Loosely correlated
-0.57%
More